Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with α- and β-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B

Polish Journal of Pharmacology

Volumn 50, Issue 3, 1998, Pages 213-223

  Wiśniewska, Róza J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

and adrenoceptors; Cardiovascular system; Cholecystokinins; Diabetes mellitus; Rat

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; ISOPRENALINE; NORADRENALIN; PHENTOLAMINE; PROPRANOLOL; STREPTOZOCIN; TETRAGASTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ADRENERGIC AGENTS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHOLECYSTOKININ; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HEART; HEART RATE; ISOPROTERENOL; MALE; NOREPINEPHRINE; PHENTOLAMINE; PROPRANOLOL; RATS; RATS, WISTAR; SINCALIDE; STREPTOZOCIN; TETRAGASTRIN;

EID: 0031859270     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bitar M. S., Koulu M., Rapoport S. I., Linnoila M.: Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetic rats. Biochem. Pharmacol., 1987, 36, 1011-1016.
2. Chang R. S., Lotti V. J., Chen T. B.: Cholecystokinin receptor mediated hydrolysis of inositol phospholipids in guinea pig gastric glands. Life Sci., 1985, 36, 965-971.
3. Christlieb A. R.: Renin, angiotensin and norepinephrine in alloxan diabetes. Diabetes, 1974, 23, 962-970.
4. Christensen N. J.: Catecholamines and diabetes mellitus. Diabetologia, 1979, 16, 211-224.
5. De Weerth A., Pisegna J. R., Wank S. A.: Guinea pig gallbladder and pancreas possess identical CCK-A receptor subtypes: receptor cloning and expression. Amer. J. Physiol., 1993, 265, G1116-G1121.
6. Durante W., Sunahara F. A., Sen A. K.: Effect of diabetes on metabolic coronary dilatation in the rat. Cardiovasc. Res., 1989, 23, 40-45.
7. Fiedorowicz R. J., Wiśniewski K.: Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system in diabetic rats. Pol. J. Pharmacol. Pharm., 1989, 41, 561-572.
8. Fiedorowicz R. J., Wiśniewski K.: The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats. Pol. J. Pharmacol. Pharm., 1989, 41, 573-583.
9. Goldfine I. D., Williams J. A.: Receptor for insulin and CCK in acinar pancreas: relationship to hormone action. Int. Rev. Cytol., 1983, 85, 1-39.
10. Gotzsche O.: The adrenergic β-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin diabetic rats: in vivo and in vitro evidence for a desensitized myocardial β-receptor. Diabetes, 1983, 32, 1110-1121.
11. Heyliger C. E., Pierce G. N., Singal P. K., Beamish R. E., Dhalla N. S.: Cardiac alpha-and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res. Cardiol., 1982, 77, 610-618.
12. 1-adrenoceptor stimulation of isolated atria from experimental diabetic rats. Can. J. Physiol. Pharmacol., 1986, 64, 145-151.
13. Jobidon C., Nadeau A., Tagrede G., Rousseau-Migneron S.: Diminished hypotensive response to isoproterenol in streptozotocin-diabetic rats. Gen. Pharmacol., 1989, 20, 39-45.
14. Kamata K., Miyata N., Abiru T., Kasuya Y.: Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci., 1992, 50, 1379-1387.
15. Kannel W. B.: Role of diabetes in cardiac disease: conclusions from population studies. In: Diabetes and the Heart. Ed. Zoncraich S. CC Thomas Publishers, Springfild, IL, 1978, 97-112.
16. Mac Leod K. M., Mc Neill J. H.: The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can. J. Physiol. Pharmacol., 1985, 63, 52-57.
17. Marinio C. R., Leach S. D., Schaefer J. F., Miller L. J., Gorelick F. S.: Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas. FEBS Lett., 1993, 316, 48-52.
18. Marsh J. D., Barry W. H., Smith T. W.: Desensitization to the inotropic effect of isoproterenol in cultured ventricular cells. J. Pharmacol. Exp. Ther., 1982, 233, 60-65.
19. Miller T. B.: Cardiac performance of isolated perfused hearts from alloxan diabetic rats. Amer. J. Physiol., 1979, 5, H808-H812.
20. Nagamine F., Murakami K., Mimura G., Sakanashi M.: Effects of beta-adrenoceptor blocking agents on isolated atrial and papillary muscles from experimentally diabetic rats. Jpn. J. Pharmacol., 1989, 49, 67-76.
21. Qian J. M., Rowley W. H., Jensen R. T.: Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors. Amer. J. Physiol., 1993, 264, G718-G727.
22. Ramanadham S., Tenner T. E. Jr.: Alterations in cardiac performance in experimentally induced diabetes. Pharmacology, 1984, 27, 130-139.
23. Ramanadham S., Tenner T. E. Jr.: Chronic efffects of streptozotocin-diabetes on myocardial sensitivity in rats. Diabetologia, 1986, 29, 741-748.
24. Ramanadham S., Tenner T. E. Jr.: Alternations in the myocardial beta-adrenoceptor system of streptozotocin diabetic rats. Eur. J. Pharmacol., 1987, 136, 377-390.
25. Rowley W. H., Sato S., Huang S. C., Collado Escobar D. M., Beaven M. A., Wang L. H., Martinez J., Gardner J. D., Jensen R. T: Cholecystokinin-induced formation of inositol phophates in pancreatic acini. Amer. J. Physiol., 1990, 259, G655-G665.
26. Savarese J. J., Berkowitz B. A.: Beta-adrenergic receptor decrease in diabetic rat hearts. Life Sci., 1979, 25, 2075-2078.
27. Simpson W. W., Rodgers R. L., Mc Neill J. H.: Cardiac responsiveness to alpha-and beta-adrenergic amines: effects of carbachol and hypothyroidism. J. Pharmacol. Exp. Ther., 1981, 219, 231-234.
28. Srivastava A. K., Anand-Srivastava M. B.: Streptozotocin-induced diabetes and hormone sensitivity of adenylate cyclase in rat myocardial sarcolemma, aorta and liver. Biochem. Pharmacol., 1985, 34, 2013-2017.
29. Sunagawa R., Murakami K., Mimura G., Sakanashi M.: Effects of adrenergic drugs on isolated and perfused hearts of streptozotocin-induced diabetic rats. Jpn. J. Pharmacol., 1987, 44, 233-240.
30. Tse J., Powell J. R., Baste R. E., Priest R. E., Kuo J. F.: Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of β-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology, 1979, 105, 246-252.
31. Wallenstein S., Zucker C. L., Fleiss J. L.: Some statistical methods useful in circulation research. Circ. Res., 1980, 47, 1-9.
32. Wiśniewska R., Wiśniewski K.: The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats. Gen. Pharmacol., 1996, 27, 159-163.
33. Wiśniewska R., Wiśniewski K.: Cholecystokinin (CCK) and C-terminal fragments of CCK: effect of CCK-33, CCK-8 and CCK-4 in the cardiovascular system of diabetic rats. Gen. Pharmacol., 1996, 27, 399-405.
34. 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. Amer. J. Physiol., 1991, 260, H557-H562.
35. Yu Z., Mc Neill J. H.: Blood pressure and heart rate response to vasoactive agents in conscious diabetic rats. Can. J. Physiol. Pharmacol., 1992, 70, 1542-1548.